Evidence map›Paper›PMID 23018346›Full record

ArticleMedical science monitor : international medical journal of experimental and clinical research2012

Coexpression of Smad7 and UPA attenuates carbon tetrachloride-induced rat liver fibrosis.

Baocan Wang, Wenxi Li, Yingwei Chen, Yuqin Wang, Chao Sun, Yuanwen Chen, Hanming Lu, Jiangao Fan, Dingguo Li

Open access · hybridAbstract read
In one paragraph

Article in Medical science monitor : international medical journal of experimental and clinical research, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. SimulatedPostepy dermatologii i alergologii · 2022
    Article
  2. Effect of medicated serum ofSaudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2017
    Article
  3. Article
  4. Article
  5. Activity of MMP1 and MMP13 and amino acid metabolism in patients with alcoholic liver cirrhosis.Medical science monitor : international medical journal of experimental and clinical research · 2015
    Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Baocan WangDepartment of Gastroenterology, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
Wenxi Li
Yingwei Chen
Yuqin Wang
Chao Sun
Yuanwen Chen
Hanming Lu
Jiangao Fan
Dingguo Li
XinHua Hospital · CNNovartis (China) · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThere is a great need for developing novel therapies to treat liver fibrosis. Previous studies showed that both Smad7 and uPA were inhibitors of liver fibrosis. Therefore, we explored the therapeutic effects of combinational gene therapy with Smad7 and uPA on CCl4-induced liver fibrosis. MATERIAL/

methodsSmad7 and uPA genes were cloned into an adenovirus vector. To observe the therapeutic effects of coexpression of Smad7 and uPA genes, the recombinant adenovirus were delivered into CCL4-induced fibrosis models. Fibrillar collagen, hydroxyproline, α-SMA, TGF-β1, MMP-13, TIMP-1, HGF and PCNA were detected to evaluate the fibrosis and to explore the mechanisms underlying the treatment with Smad7 and uPA.

resultsThe results showed that single Smad7 or uPA adenovirus reduced CCL4 induced liver fibrosis significantly; while combination of Smad7 and uPA had more significant therapeutic effect on CCl4 induced liver fibrosis. Then the markers underlying the therapeutic effect of combination of Smad7 and uPA were also explored. Over-expression of Smad7 and uPA inhibited the expression of α-SMA and TGF- β1 significantly. Combinational gene therapy also enhanced extracellular matrix degradation by increasing the expression of MMP-13, inhibiting TIMP-1 expression, and promoted hepatocyte proliferation, while single Smad7 or uPA only induced part of these changes.

conclusionsThese results suggest that combinational gene therapy with Smad7 and uPA inhibited CCl4-induced rat liver fibrosis by simultaneously targeting multiple pathogenic pathways.

Indexed as

Genetic TherapyAdenoviridaeAnimalsCarbon TetrachlorideCell ProliferationDisease ProgressionExtracellular MatrixGene Expression Regulation, EnzymologicHepatocytesImmunohistochemistryLiverLiver CirrhosisMaleMatrix Metalloproteinase 13RatsRats, Sprague-DawleyCarbon TetrachlorideMatrix Metalloproteinase 13RNA, MessengerSmad7 ProteinSmad7 protein, ratTissue Inhibitor of Metalloproteinase-1Transforming Growth Factor beta1Urokinase-Type Plasminogen Activator

Identifiers

PMID23018346
PMCPMC3560566
OpenAlexW2040147846

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.